Curemark announced today that it has been chosen to present at the 2008 Life Sciences and Healthcare Venture Summit October 30, 2008 to be held in New York City.
Rye, NY (PRWEB) October 29, 2008 -- Curemark announced today that it has been chosen to present at the 2008 Life Sciences and Healthcare Venture Summit October 30, 2008 to be held in New York City.
The 2008 Life Sciences and Healthcare Venture Summit presented by Young Startup Ventures is the premier bioscience industry gathering, connecting senior executives of the early stage biotech, pharmaceutical, healthcare, medical device and diagnostic companies with venture capitalists, angel investors, corporate VCs and professional service firms.
Sponsored by such important industry leaders as Pillsbury, KPMG, New York City Bioscience Initiative, ADP, Cooley Godward Kronish, Morgan Lewis, Young Startup Ventures and Intel Capital, the Summit organizers state that the Summit features 40 of the "hottest emerging companies".
"The Summit is considered to be the premier bioscience industry gathering," states Curemark CEO Dr. Joan Fallon. " We are honored to have been chosen to present at this prestigious event."
Curemark is a biotechnology company focused on the treatment of neurological and other diseases by addressing certain key gastrointestinal/pancreatic secretory deficiencies. The company's initial products are based upon breakthrough observations by its founder, Dr. Joan Fallon. The company is currently preparing for clinical trials. To learn more about our innovative science, please visit: www.cure-mark.com.
Read the full story at http://www.prweb.com/releases/bioscience_industry/summit/prweb1538004.htm
Copyright©2008 Vocus, Inc.
All rights reserved